|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) attributable to common shareholders | |||||
| NewStem Ltd | |||||
| Total net income (loss) attributable to common shareholders | |||||
| Adjustments to reconcile net income (loss) to cash used in operating activities: | |||||
| Depreciation | |||||
| NewStem Ltd | |||||
| Revaluation of convertible financial instrument | |||||
| Equity in net loss of equity method investees | |||||
| Equity in net loss of equity method investees | |||||
| Impairment loss | |||||
| Gain on dilution of equity method investment | |||||
| Distribution from NetCo | |||||
| Impairment loss, NewStem | |||||
| Bad debt expense | |||||
| Accretion of discount on note payable | |||||
| Loss on derivative instrument | |||||
| Legal fees and litigation funding fees funded by litigation funding agreement | |||||
| Gain on disposal of equity method investment | |||||
| Relief of indebtedness income | |||||
| Accrued interest added to short term notes payable | |||||
| Accrued interest added to long-term notes payable | |||||
| Accrued interest added to bridge loan payable | |||||
| Accrued interest added to convertible debt | |||||
| Stock-based compensation | |||||
| NewStem Ltd | |||||
| Total stock-based compensation | |||||
| Change in operating assets and liabilities: | |||||
| Decrease in other current assets | |||||
| Accounts receivable, administrative fees | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| NewStem Ltd | |||||
| Total accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| NewStem Ltd | |||||
| Total net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Loans made | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from convertible debt | |||||
| Proceeds from note payable, current | |||||
| Funds received from a related party | |||||
| Proceeds from long-term note payable | |||||
| Proceeds from bridge loan payable | |||||
| Net cash provided by financing activities | |||||
| NewStem Ltd | |||||
| Total net cash provided by financing activities | |||||
| Net change in cash | |||||
| NewStem Ltd | |||||
| Total net change in cash | |||||
| Cash at the beginning of the year | |||||
| NewStem Ltd | |||||
| Total cash at the beginning of the year | |||||
| Cash at the end of the year | |||||
| NewStem Ltd | |||||
| Total cash at the end of the year | |||||
| Supplemental cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Conversion of convertible financial instrument | |||||
| Supplemental Non-Cash Investing and Financing Activities: | |||||
| Interest added to notes payable and convertible debt | |||||
| Interest capitalized to notes payable | |||||
| Settlement of long term notes payable | |||||
| Settlement of derivative liability, net of interest | |||||
Loading...